Suppr超能文献

甲胎蛋白在确定肝细胞癌切除边缘中的临床相关性。

Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma.

作者信息

Lee Jin-Chiao, Cheng Chih-Hsien, Wang Yu-Chao, Wu Tsung-Han, Lee Chen-Fang, Wu Ting-Jung, Chou Hong-Shiue, Chan Kun-Ming, Lee Wei-Chen

机构信息

Division of Liver and Transplantation Surgery, Department of General Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan.

出版信息

Medicine (Baltimore). 2019 Mar;98(11):e14827. doi: 10.1097/MD.0000000000014827.

Abstract

Liver resection for hepatocellular carcinoma (HCC) is associated with high recurrence rates. Adequate resection margin which is carried out by surgeons may reduce tumor recurrence. Nevertheless, the margin width remains controversial particularly in cirrhotic patients where optimal parenchymal preservation is necessary. This study aims to find a reference for proposing the resection margin when liver resection is planning.Totally, 534 patients who received liver resection for HCC were included. The clinical profiles of the patients, tumor characteristics and patients' survival were all collected. The patients were classified according to resection margin (<0.5 cm, 0.5-0.99 cm, and ≥1 cm) and preoperative α-fetoprotein (AFP) levels (<15 ng/ml, 15-200 ng/ml, and >200 ng/ml), then survival was calculated.Most of the patients had hepatitis B (52.4%) and hepatitis C (24.0%) infection. Multivariate analysis showed that narrow resection margin (<0.5 cm) (hazard ratio [HR]: 1.323, P = .024), high AFP level (≥15 ng/ml) (HR: 1.305, P = .039), major extent of resection (≥3 segments) (HR: 1.507, P = .034), and underlying cirrhosis (HR: 1.404, P = .009) were independent risk factors for disease-free survival. In further survival analysis, resection margin was not significant for disease-free survival if serum AFP levels were <15ng/ml. However, for the patients with AFP level between 15 and 200 ng/ml, resection margin ≥0.5 cm was significant to improve 5-year disease-free survival from 24.6 months to 38.7 months (P = .040). For the patients with AFP >200 ng/ml, resection margin had to be extended to ≥1 cm to improve 5-year disease-free survival from 33.9 months to 48.8 months (P = .012). When the patients meeting AFP <15 ng/ml with tumor-free margin, AFP between 15 and 200 ng/ml with margin ≥0.5 cm, and AFP level >200 ng/ml with margin ≥1 cm were compared, their survival rates were not different.Adequate resection margin can be guided by pre-operative AFP levels. Tumor-free margin is enough for patients with normal AFP level. A resection margin ≥0.5 cm is advised for the patients with AFP between 15 and 200 ng/ml, and ≥1 cm for the patients with AFP over 200 ng/ml.

摘要

肝细胞癌(HCC)肝切除术的复发率较高。外科医生进行的足够切缘可能会降低肿瘤复发率。然而,切缘宽度仍存在争议,尤其是在需要优化实质保留的肝硬化患者中。本研究旨在为肝切除手术规划时提出切缘提供参考。

总共纳入了534例行HCC肝切除术的患者。收集了患者的临床资料、肿瘤特征和患者生存情况。根据切缘(<0.5厘米、0.5 - 0.99厘米和≥1厘米)和术前甲胎蛋白(AFP)水平(<15纳克/毫升、15 - 200纳克/毫升和>200纳克/毫升)对患者进行分类,然后计算生存率。

大多数患者有乙型肝炎(52.4%)和丙型肝炎(24.0%)感染。多因素分析显示,切缘狭窄(<0.5厘米)(风险比[HR]:1.323,P = 0.024)、AFP水平高(≥15纳克/毫升)(HR:1.305,P = 0.039)、切除范围大(≥3个肝段)(HR:1.507,P = 0.034)和潜在肝硬化(HR:1.404,P = 0.009)是无病生存的独立危险因素。在进一步的生存分析中,如果血清AFP水平<15纳克/毫升,切缘对无病生存无显著影响。然而,对于AFP水平在15至照200纳克/毫升之间的患者,切缘≥0.5厘米可显著将5年无病生存率从24.6个月提高到38.7个月(P = 0.040)。对于AFP>200纳克/毫升的患者,则必须将切缘扩大至≥1厘米,才能将5年无病生存率从33个月提高到48.8个月(P = 0.012)。比较AFP<15纳克/毫升且切缘无肿瘤、AFP在15至200纳克/毫升之间且切缘≥0.5厘米、AFP水平>200纳克/毫升且切缘≥1厘米的患者,其生存率无差异。

术前AFP水平可指导确定足够的切缘。AFP水平正常的患者切缘无肿瘤即可。建议AFP在15至200纳克/毫升之间的患者切缘≥0.5厘米,AFP超过200纳克/毫升的患者切缘≥1厘米。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3c/6426617/f2bb86479f37/medi-98-e14827-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验